Literature DB >> 20872838

Squamous cell cancer of the head and neck with distant metastasis at presentation.

David I Kuperman1, Vorachart Auethavekiat, Douglas R Adkins, Brian Nussenbaum, Sharon Collins, Chaiyaporn Boonchalermvichian, Kathryn Trinkaus, Ling Chen, Daniel Morgensztern.   

Abstract

BACKGROUND: Current literature reports widely different rates of distant metastasis at presentation for squamous cell carcinoma of the head and neck (SCCHN). We used the Surveillance Epidemiology and End Results (SEER) database to determine the rate of and risk factors for distant metastasis.
METHODS: We identified patients with SCCHN diagnosed between 1988 and 2003. The rate of distant metastasis was determined and then stratified by tumor site, size, and nodal status. To evaluate the contribution of each individual factor, both univariate and multivariate analyses were performed.
RESULTS: Among 73,247 patients identified, 2066 patients (2.82%, 95% confidence interval [CI] 2.70-2.94%) had distant metastasis. Independent risk factors for distant metastasis included primary site, nodal status, tumor size, age, and race.
CONCLUSIONS: In SCCHN, there is a relationship between the risk of distant metastasis and tumor site, size, and nodal status. This information can be used to guide the evaluation and treatment of SCCHN.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20872838     DOI: 10.1002/hed.21529

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  25 in total

1.  The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Authors:  Francesco Carinci; Lorenzo Monasta; Corrado Rubini; Daniela Stramazzotti; Annalisa Palmieri; Elisabetta Melloni; Alex Knowles; Luca Ronfani; Giorgio Zauli; Paola Secchiero
Journal:  Invest New Drugs       Date:  2010-11-18       Impact factor: 3.850

2.  Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.

Authors:  Steven B Chinn; Owen A Darr; John H Owen; Emily Bellile; Jonathan B McHugh; Matthew E Spector; Silvana M Papagerakis; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E P Prince
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

3.  Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Chih-Hua Yeh; Sheng-Chieh Chan; Chien-Yu Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Chun-Ta Liao; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

4.  Predictive factors for simultaneous distant metastasis in head and neck cancer patients during the diagnostic work-up.

Authors:  Carlos Miguel Chiesa-Estomba; Maria Soriano-Reixach; Ekhiñe Larruscain-Sarasola; Jon Alexander Sistiaga-Suarez; Jose Angel González-García; Amaia Sanchez-Martin; Laura Basterretxea-Badiola; Naiara Sagastibelta; Xabier Altuna-Mariezcurrena
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-07       Impact factor: 2.503

Review 5.  Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Eliane Tang; Lucien Lahmi; Nicolas Meillan; Gianandrea Pietta; Sébastien Albert; Philippe Maingon
Journal:  Curr Oncol Rep       Date:  2019-11-14       Impact factor: 5.075

Review 6.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 7.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

8.  Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.

Authors:  Zachary S Zumsteg; Michael Luu; Emi J Yoshida; Sungjin Kim; Mourad Tighiouart; John M David; Stephen L Shiao; Alain C Mita; Kevin S Scher; Eric J Sherman; Nancy Y Lee; Allen S Ho
Journal:  Cancer       Date:  2017-08-17       Impact factor: 6.921

9.  Prognostic factors of cervical node status in head and neck squamous cell carcinoma.

Authors:  Chairat Burusapat; Weerawut Jarungroongruangchai; Mongkon Charoenpitakchai
Journal:  World J Surg Oncol       Date:  2015-02-15       Impact factor: 2.754

10.  Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck.

Authors:  Clémence Guenne; Jérôme Fayette; Alain Cosmidis; Carine Fuchsmann; Sophie Tartas; Véronique Favrel; Philippe Céruse
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.